167 related articles for article (PubMed ID: 37958303)
1. CD30 Lateral Flow and Enzyme-Linked Immunosorbent Assays for Detection of BIA-ALCL: A Pilot Study.
Zeyl VG; Xu H; Khan I; Machan JT; Clemens MW; Hu H; Deva A; Glicksman C; McGuire P; Adams WP; Sieber D; Sinha M; Kadin ME
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958303
[TBL] [Abstract][Full Text] [Related]
2. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
[TBL] [Abstract][Full Text] [Related]
3. Comparative Analysis of Cytokines of Tumor Cell Lines, Malignant and Benign Effusions Around Breast Implants.
Kadin ME; Morgan J; Kouttab N; Xu H; Adams WP; Glicksman C; McGuire P; Sieber D; Epstein AL; Miranda RN; Clemens MW
Aesthet Surg J; 2020 May; 40(6):630-637. PubMed ID: 31589747
[TBL] [Abstract][Full Text] [Related]
4. Use of flow cytometry and cytology to differentiate breast implant-associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients.
De Azambuja AP; Gevert F; Oliveira RM; Sebastião AP; Groth AK
Cytometry B Clin Cytom; 2022 Jul; 102(4):312-316. PubMed ID: 34791787
[TBL] [Abstract][Full Text] [Related]
5. Granzyme B Is a Biomarker for Suspicion of Malignant Seromas Around Breast Implants.
Kadin ME; Morgan J; Xu H; Glicksman C; Sieber D; Adams WP; McGuire P; Clemens MW; Thakur A; Lum LG
Aesthet Surg J; 2021 Nov; 41(12):1359-1364. PubMed ID: 33165542
[TBL] [Abstract][Full Text] [Related]
6. What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Kadin ME
Aesthet Surg J; 2019 Jan; 39(Suppl_1):S28-S35. PubMed ID: 30715174
[TBL] [Abstract][Full Text] [Related]
7. IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas.
Di Napoli A; Greco D; Scafetta G; Ascenzi F; Gulino A; Aurisicchio L; Santanelli Di Pompeo F; Bonifacino A; Giarnieri E; Morgan J; Mancini R; Kadin ME
Cancer Immunol Immunother; 2021 May; 70(5):1379-1392. PubMed ID: 33146828
[TBL] [Abstract][Full Text] [Related]
8. CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Morgan J; Wei W; Song Z; Yang Y
Aesthet Surg J; 2023 Feb; 43(2):137-146. PubMed ID: 35999655
[TBL] [Abstract][Full Text] [Related]
9. Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?
Kadin ME; Xu H; Hunsicker LM; Guan Y
Aesthet Surg J; 2022 Jan; 42(2):NP125-NP129. PubMed ID: 33944901
[TBL] [Abstract][Full Text] [Related]
10. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
Kadin ME; Adams WP; Inghirami G; Di Napoli A
Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
[TBL] [Abstract][Full Text] [Related]
11. Breast implant associated anaplastic large cell lymphoma: Evidence for an efficient diagnostic workup.
Vittoria L; Sala L; Summo V; Capone I; Conca E; Toma M; Ottolenghi J; Testa F; Cortinovis U; Paolini B; Cabras A; Aiello A; Bozzi F
Tumori; 2023 Oct; 109(5):458-465. PubMed ID: 36942354
[TBL] [Abstract][Full Text] [Related]
12. A Cautionary Tale and Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Ghosh T; Duncavage E; Mehta-Shah N; McGuire PA; Tenenbaum M; Myckatyn TM
Aesthet Surg J; 2020 Nov; 40(12):1288-1300. PubMed ID: 31894234
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
Fleming D; Stone J; Tansley P
Aesthetic Plast Surg; 2018 Jun; 42(3):672-678. PubMed ID: 29445921
[TBL] [Abstract][Full Text] [Related]
14. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.
D'Alessandris N; Lucatelli P; Tripodi D; Amabile MI; Ascoli V
Diagn Cytopathol; 2019 Nov; 47(11):1213-1217. PubMed ID: 31348611
[TBL] [Abstract][Full Text] [Related]
15. Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL).
Lee JH
Yeungnam Univ J Med; 2021 Jul; 38(3):175-182. PubMed ID: 33461261
[TBL] [Abstract][Full Text] [Related]
16. Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.
Di Napoli A; Pepe G; Giarnieri E; Cippitelli C; Bonifacino A; Mattei M; Martelli M; Falasca C; Cox MC; Santino I; Giovagnoli MR
PLoS One; 2017; 12(7):e0181097. PubMed ID: 28715445
[TBL] [Abstract][Full Text] [Related]
17. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
Fleming D; Stone J; Tansley P
Aesthetic Plast Surg; 2020 Aug; 44(4):1109-1115. PubMed ID: 32766915
[TBL] [Abstract][Full Text] [Related]
19. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Morgan J; Xu H; Glicksman CA
Aesthet Surg J; 2017 Jul; 37(7):771-775. PubMed ID: 28402493
[TBL] [Abstract][Full Text] [Related]
20. What are the likely causes of breast implant associated anaplastic large cell lymphoma (BIA-ALCL)?
Lajevardi SS; Rastogi P; Isacson D; Deva AK
JPRAS Open; 2022 Jun; 32():34-42. PubMed ID: 35242986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
